Advertisement
Canada markets closed
  • S&P/TSX

    22,269.12
    +197.41 (+0.89%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • DOW

    38,686.32
    +574.84 (+1.51%)
     
  • CAD/USD

    0.7339
    +0.0028 (+0.38%)
     
  • CRUDE OIL

    77.18
    -0.73 (-0.94%)
     
  • Bitcoin CAD

    92,335.46
    -608.90 (-0.66%)
     
  • CMC Crypto 200

    1,423.28
    -5.29 (-0.37%)
     
  • GOLD FUTURES

    2,347.70
    -18.80 (-0.79%)
     
  • RUSSELL 2000

    2,070.13
    +13.53 (+0.66%)
     
  • 10-Yr Bond

    4.5140
    -0.0400 (-0.88%)
     
  • NASDAQ

    16,735.02
    -2.06 (-0.01%)
     
  • VOLATILITY

    12.92
    -1.55 (-10.71%)
     
  • FTSE

    8,275.38
    +44.33 (+0.54%)
     
  • NIKKEI 225

    38,487.90
    +433.77 (+1.14%)
     
  • CAD/EUR

    0.6762
    +0.0016 (+0.24%)
     

Velan Inc. Reports Its Fiscal 2024 Fourth Quarter and Year-End Results

Velan Inc.
Velan Inc.

Strong new order inflow and higher backlog¹ entering fiscal 2025

MONTREAL, May 16, 2024 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless indicated otherwise.

FOURTH QUARTER HIGHLIGHTS:

  • Bookings1 of $132.8 million, up sharply from $87.1 million last year and $78.3 million in the third quarter.

  • Book-to-bill1 ratio of 1.13, versus 0.76 for the same period a year ago and 0.97 in the third quarter.

  • Sales of $117.9 million, up from $115.1 million last year and up from $80.9 million in the third quarter.

  • Gross profit of $38.4 million, or 32.6% of sales, compared to $39.9 million, or 30.4% of sales, last year.

  • Net loss2 of $2.1 million compared to a net loss of $47.2 million last year.

ADVERTISEMENT

YEAR-END HIGHLIGHTS:

  • Order backlog1 of $491.5 million, up $27.1 million from last year.

  • Bookings of $374.5 million, compared to $353.2 million in fiscal 2023.

  • Book-to-bill ratio of 1.08, versus 0.95 last year.

  • Sales of $346.8 million, compared to $370.4 million in fiscal 2023.

  • Gross profit of $93.2 million, or 26.9% of sales, versus $112.5 million, or 30.4% of sales, last year.

  • Net loss of $19.7 million, versus a net loss of $55.5 million in the prior year.

  • Cash and cash equivalents of $36.4 million.

FINANCIAL RESULTS
(‘000s of U.S. dollars, excluding per share amounts)

Three-month periods ended

Fiscal years ended

Feb. 29, 2024

Feb. 28, 2023

Feb. 29, 2024

Feb. 28, 2023

Sales

 

$117,894

 

$115,141

 

$346,816

 

$370,429

 

Gross profit

 

$38,384

 

$39,945

 

$93,207

 

$112,465

 

Gross margin

 

32.6%

 

34.7%

 

26.9%

 

30.4%

 

Net loss

 

($2,083)

 

($47,164)

 

($19,737)

 

($55,453)

 

per share - basic and diluted

 

($0.10)

 

($2.18)

 

($0.91)

 

($2.57)

 

Adjusted EBITDA

 

$19,879

 

$16,468

 

$17,780

 

$21,092

 

Adjusted net income (loss)

 

$8,944

 

$8,790

 

($7,918)

 

$501

 

per share - basic and diluted

 

$0.41

 

$0.41

 

($0.37)

 

$0.02

 

Weighted average share outstanding (‘000s)

 

21,586

 

21,586

 

21,586

 

21,586

 


“Velan concluded fiscal 2024 with strong fourth quarter results, marked by heightened sales volume and healthy profit margins on improved quality of execution,” said James A. Mannebach, Chairman and CEO of Velan. “In addition, robust bookings during the period further increased our backlog to $491.5 million at year-end. Given the value of orders to be shipped over the next 12 months, we expect sales growth in fiscal 2025. As a supplier of critical equipment to essential industries, Velan is well positioned to capture growth opportunities driven by the ongoing energy transition and expand its reach in the flow control industry based on an agile workforce, global presence and strong brand recognition.”

“Fueled by a net cash position, Velan’s strong balance sheet will allow the Company to fund its current operations and pursue re-investment to expand its global reach. Over the longer term, we remain committed to building shareholder value through sales and cash flow growth,” added Rishi Sharma, Chief Financial and Administrative Officer of Velan.

BOOKINGS AND BACKLOG
(‘000s of U.S. dollars, excluding ratio)

 

Three-month periods ended

Fiscal years ended

 

Feb. 29, 2024

Feb. 28, 2023

Feb. 29, 2024

Feb. 28, 2023

Backlog

 

 

 

$491,525

 

$464,337

 

for delivery within the next 12 months

 

 

 

$360,669

 

$307,991

 

Bookings

 

$132,825

 

$87,085

 

$374,454

 

$353,176

 

Book-to-bill ratio

 

 

1.13

 

 

0.76

 

 

1.08

 

 

0.95

 


As at February 29, 2024, the backlog stood at $491.5 million, up $27.2 million, or 5.9%, from $464.3 million a year earlier reflecting strong fourth quarter bookings. As at February 29, 2024, 73.4% of the backlog, representing orders of $360.7 million, is deliverable in the next 12 months, versus 66.3% of last year’s backlog. Currency movements had a positive effect of $5.6 million on the backlog during the year.

Bookings for the fourth quarter of fiscal 2024 amounted to $132.8 million, up 52.5% over bookings of $87.1 million a year earlier. The increase is mainly attributable to strong oil and gas bookings recorded by the Company’s Italian operations and to higher orders recorded by North American operations, partially offset by the timing of orders for the French subsidiary following strong bookings in the prior year. Currency movements had a positive effect of $3.8 million on bookings during the quarter.

As a result of bookings outpacing sales, the Company’s book-to-bill ratio was 1.13 in the fourth quarter of fiscal 2024, compared to 0.76 in the corresponding period of fiscal 2023.

Fiscal 2024 bookings reached $374.5 million, an increase of $21.3 million or 6.0% compared to the previous year. As a result of bookings outpacing sales for the fiscal year, the Company’s book-to-bill ratio was 1.08 in fiscal 2024, compared with 0.95 in fiscal 2023.

FISCAL 2024 FOURTH QUARTER RESULTS

Sales reached $117.9 million, up $2.8 million or 2.4% from last year. The variation is mostly attributable to stronger shipments from the Company’s International operations. These factors were partially offset by lower shipments from North American operations and shipping delays due to the situation in the Red Sea. Currency movements had a $1.7 million positive effect on sales for the quarter.

Gross profit was $38.4 million, versus $39.9 million a year ago. The variation reflects a less favorable product mix this year compared to last due to the execution of certain low margin projects. Last year’s gross profit also benefitted from a favorable revaluation of the inventory provision based on new estimates relating to changes in market demand. As a percentage of sales, gross profit was 32.6%, versus 34.7% last year.

Administration costs reached $33.1 million, compared to $80.8 million last year. This year’s administration costs include a $10.0 million asbestos provision adjustment and restructuring charges of $1.3 million mostly consisting of severances. Last year’s costs included a $56.0 million charge to increase the Company’s asbestos provision. Excluding these items, administration costs totaled $21.7 million, or 18.4% of sales, in the fourth quarter of fiscal 2024, versus $24.9 million, or 21.6% of sales, in the fourth quarter of fiscal 2023. The decrease is mostly due to lower expenses for the North American operations and cost reduction initiatives throughout the Company’s operations.

EBITDA1 reached $8.5 million compared to negative $39.5 million last year. Excluding asbestos and restructuring costs, adjusted EBITDA was $19.9 million in the fourth quarter of fiscal 2024, compared to $16.5 million a year earlier. This increase reflects lower administration costs and a $1.7 million net reduction in other expenses, mainly related to a provision related to a commodity tax audit last year. These factors were partially offset by a lower gross profit.

Net loss was $2.1 million, or $0.10 per share, versus a net loss of $47.2 million, or $2.18 per share last year. Excluding the after-tax effect of asbestos and restructuring costs, adjusted net income was $8.9 million, or $0.41 per share, compared to $8.8 million, or $0.41 per share, last year. The variation is attributable to higher adjusted EBITDA partially offset by higher net finance costs and income tax expense.

YEAR-END RESULTS

For the fiscal year ended February 29, 2024, sales amounted to $346.8 million, down from $370.4 million last year. Gross profit was $93.2 million, or 26.9% of sales, compared to $112.5 million, or 30.4% of sales, last year. EBITDA stood at $5.3 million, versus negative $34.9 million a year ago, while adjusted EBITDA reached $17.8 million compared to $21.1 million last year. Net loss was $19.7 million, or $0.91 per share, compared to a net loss of $55.5 million, or $2.57 per share, a year ago, while adjusted net loss was $7.9 million, or $0.37 per share, compared to adjusted net income of $0.5 million, or $0.02 per share in the prior year.

FINANCIAL POSITION

As at February 29, 2024, Velan’s financial position remained solid. The Company had cash and cash equivalents of $36.4 million, as well as short-term investments of $5.3 million, while long-term debt, including the current portion, amounted to $28.8 million.

OUTLOOK

Velan aims to build on the momentum gained in the second half of fiscal 2024, concluding the year on a solid note with a growing order backlog and a book-to-bill ratio of 1.08. As at February 29, 2024, orders totaling $360.7 million, representing 73.4% of a total backlog of $491.5 million, are expected to be delivered in the next 12 months. Given these orders, the Company expects to deliver annual sales in fiscal 2025 above the level achieved in fiscal 2024.

CONFERENCE CALL NOTICE

Financial analysts, shareholders, and other interested individuals are invited to attend the fourth quarter conference call to be held on Friday, May 17, 2024, at 8:00 a.m. (EDT). The toll-free call-in number is 1-888-660-6345 or 1-289-819-1450. The material that will be referenced during the conference call will be made available shortly before the event on the company’s website under the Investor Relations section (https://www.velan.com/en/company/investor_relations). A recording of this conference call will be available for seven days at 1-289-819-1450 or 1-888-660-6345, access code 24455.

ABOUT VELAN

Founded in Montreal in 1950, Velan Inc. (www.velan.com) is one of the world’s leading manufacturers of industrial valves, with sales of US$346.8 million in its last reported fiscal year. The Company employs approximately 1,641 people and has manufacturing plants in 9 countries. Velan Inc. is a public company with its shares listed on the Toronto Stock Exchange under the symbol VLN.

SAFE HARBOUR STATEMENT

This news release may include forward-looking statements, which generally contain words like “should”, “believe”, “anticipate”, “plan”, “may”, “will”, “expect”, “intend”, “continue” or “estimate” or the negatives of these terms or variations of them or similar expressions, all of which are subject to risks and uncertainties, which are disclosed in the Company’s filings with the appropriate securities commissions. While these statements are based on management’s assumptions regarding historical trends, current conditions and expected future developments, as well as other factors that it believes are reasonable and appropriate in the circumstances, no forward-looking statement can be guaranteed and actual future results may differ materially from those expressed herein. The Company disclaims any intention or obligation to update or revise any forward-looking statements contained herein whether as a result of new information, future events or otherwise, except as required by the applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

NON-IFRS AND SUPPLEMENTARY FINANCIAL MEASURES

In this press release, the Company has presented measures of performance or financial condition which are not defined under IFRS (“non-IFRS measures”) and are, therefore, unlikely to be comparable to similar measures presented by other companies. These measures are used by management in assessing the operating results and financial condition of the Company and are reconciled with the performance measures defined under IFRS. The Company has also presented supplementary financial measures which are defined at the end of this report. Reconciliation and definition can be found below.

Adjusted net income, Adjusted net income per share, Earnings before interest, taxes, depreciation and amortization ("EBITDA") and Adjusted EBITDA

(thousands, except amount per shares)

 

Three-month period ended

Fiscal years ended

 

Feb. 29, 2024

Feb. 28, 2023

Feb. 29, 2024

Feb. 28, 2023

 

 

$

 

$

 

$

 

$

 

Reconciliation of net income (loss) to adjusted net income (loss)2& adjusted net income (loss) per share

 

 

 

 

 

Net income (loss)

 

(2,083

)

(47,164

)

(19,737

)

(55,453

)

Adjustment for:

 

 

 

 

 

Proposed transaction related costs

 

108

 

-

 

900

 

-

 

Restructuring costs

 

919

 

-

 

919

 

-

 

Adjustment to asbestos provision

 

10,000

 

55,954

 

10,000

 

55,954

 

Adjusted net income (loss)

 

8,944

 

8,790

 

(7,918

)

501

 

per share - basic and diluted

 

0.41

 

0.41

 

(0.37

)

0.02

 

 

 

 

 

 

 

Reconciliation of net income (loss) to Adjusted EBITDA

 

 

 

 

 

Net income (loss)

 

(2,083

)

(47,164

)

(19,737

)

(55,453

)

Adjustments for:

 

 

 

 

 

Depreciation of property, plant and equipment

 

2,472

 

2,452

 

8,930

 

8,722

 

Amortization of intangible assets and financing costs

 

650

 

608

 

2,296

 

2,272

 

Finance costs – net

 

2,355

 

516

 

6,346

 

1,552

 

Income taxes

 

5,088

 

4,102

 

7,471

 

8,045

 

EBITDA

 

8,482

 

(39,486

)

5,306

 

(34,862

)

 

 

 

 

 

 

Adjustments for:

 

 

 

 

 

Proposed transaction related costs

 

147

 

-

 

1,224

 

-

 

Restructuring costs

 

1,250

 

-

 

1,250

 

-

 

Adjustment to asbestos provision

 

10,000

 

55,954

 

10,000

 

55,954

 

Adjusted EBITDA

 

19,879

 

16,468

 

17,780

 

21,092

 


The term “Adjusted net income (loss)” is defined as net income or loss attributable to Subordinate and Multiple Voting Shares plus adjustment, net of income taxes, for costs related to the proposed transaction, restructuring, and asbestos provision. The terms “Adjusted net income (loss) per share” is obtained by dividing Adjusted net income (loss) by the total amount of subordinate and multiple voting shares. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.

The term “EBITDA” is defined as adjusted net income plus depreciation of property, plant & equipment, plus amortization of intangible assets, plus net finance costs, plus income tax provision. The term “Adjusted EBITDA” is defined as EBITDA plus adjustment for costs related to the proposed transaction, restructuring, and asbestos provision. The forward-looking statements contained in this MD&A are expressly qualified by this cautionary statement.

Definitions of supplementary financial measures

The term “Net new orders” or “bookings” is defined as firm orders, net of cancellations, recorded by the Company during a period. Bookings are impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the Company’s sales operation performance for a given period as well as well as an expectation of future sales and cash flows to be achieved on these orders.

The term “backlog” is defined as the buildup of all outstanding bookings to be delivered by the Company. The Company’s backlog is impacted by the fluctuation of foreign exchange rates for a given period. The measure provides an indication of the future operational challenges of the Company as well as an expectation of future sales and cash flows to be achieved on these orders.

The term “book-to-bill” is obtained by dividing bookings by sales. The measure provides an indication of the Company’s performance and outlook for a given period.

The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Contact:

Rishi Sharma, Chief Financial and Administrative Officer

Martin Goulet, M.Sc., CFA

Velan Inc.

MBC Capital Markets Advisors

Tel: (438) 817-4430

Tel.: (514) 731-0000, ext. 229

_______________________
1
Non-IFRS and supplementary financial measures. Refer to the Non-IFRS and supplementary financial measures section for definitions and reconciliations.
2 Net income or loss refer to net income or loss attributable to Subordinate and Multiple Voting Shares.


Consolidated Statements of Financial Position

(in thousands of U.S. dollars)

 

 

 

 

As at

 

 

 

February 29,

 

February 28,

 

 

 

2024

 

2023

 

 

 

$

 

$

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

36,445

 

50,513

 

Short-term investments

 

5,271

 

37

 

Accounts receivable

 

119,914

 

121,053

 

Income taxes recoverable

 

6,132

 

6,195

 

Inventories

 

208,702

 

202,649

 

Deposits and prepaid expenses

 

10,421

 

7,559

 

Derivative assets

 

125

 

107

 

 

 

387,010

 

388,113

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment

 

69,918

 

68,205

 

Intangible assets and goodwill

 

16,543

 

16,153

 

Deferred income taxes

 

5,193

 

4,663

 

Other assets

 

729

 

723

 

 

 

 

 

 

 

 

 

92,383

 

89,744

 

 

 

 

 

 

 

Total assets

 

479,393

 

477,857

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Bank indebtedness

 

-

 

260

 

Accounts payable and accrued liabilities

 

88,230

 

79,408

 

Income taxes payable

 

1,568

 

2,832

 

Customer deposits

 

30,396

 

28,201

 

Provisions

 

14,129

 

16,485

 

Derivative liabilities

 

26

 

299

 

Current portion of long-term lease liabilities

 

1,607

 

1,298

 

Current portion of long-term debt

 

24,431

 

8,177

 

 

 

160,387

 

136,960

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Long-term lease liabilities

 

11,036

 

9,458

 

Long-term debt

 

4,346

 

21,719

 

Income taxes payable

 

2,325

 

933

 

Deferred income taxes

 

3,462

 

3,966

 

Customer deposits

 

35,082

 

27,937

 

Provisions

 

74,058

 

70,924

 

Other liabilities

 

5,438

 

5,125

 

 

 

 

 

 

 

 

 

135,747

 

140,062

 

 

 

 

 

 

 

Total liabilities

 

296,134

 

277,022

 

 

 

 

 

 

 

Total equity

 

183,259

 

200,835

 

 

 

 

 

 

 

Total liabilities and equity

 

479,393

 

477,857

 


Consolidated Statements of Loss

(in thousands of U.S. dollars, excluding number of shares and per share amounts)

 

 

Three-month periods ended

 

 

Fiscal years ended

 

 

 

February 29,

 

February 28,

 

 

February 29,

 

February 28,

 

 

 

2024

 

2023

 

 

2024

 

2023

 

 

 

$

 

$

 

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

117,894

 

115,141

 

 

346,816

 

370,429

 

 

 

 

 

 

 

 

Cost of sales

 

79,510

 

75,196

 

 

253,609

 

257,964

 

 

 

 

 

 

 

 

Gross profit

 

38,384

 

39,945

 

 

93,207

 

112,465

 

 

 

 

 

 

 

 

Administration costs

 

33,121

 

80,841

 

 

98,744

 

156,759

 

Other expense (income)

 

(91

)

1,700

 

 

448

 

1,568

 

 

 

 

 

 

 

 

Operating profit (loss)

 

5,354

 

(42,596

)

 

(5,985

)

(45,862

)

 

 

 

 

 

 

 

Finance income

 

64

 

240

 

 

459

 

467

 

Finance costs

 

(2,419

)

(758

)

 

(6,805

)

(2,019

)

 

 

 

 

 

 

 

Finance costs – net

 

(2,355

)

(518

)

 

(6,346

)

(1,552

)

 

 

 

 

 

 

 

Income (loss) before income taxes

 

2,999

 

(43,114

)

 

(12,331

)

(47,414

)

 

 

 

 

 

 

 

Income tax expense

 

5,088

 

4,102

 

 

7,471

 

8,045

 

 

 

 

 

 

 

 

Net loss for the period

 

(2,089

)

(47,216

)

 

(19,802

)

(55,459

)

 

 

 

 

 

 

 

Net income (loss) attributable to:

 

 

 

 

 

 

Subordinate Voting Shares and Multiple Voting Shares

 

(2,083

)

(47,164

)

 

(19,737

)

(55,453

)

Non-controlling interest

 

(6

)

(52

)

 

(65

)

(6

)

 

 

 

 

 

 

 

Net loss for the period

 

(2,089

)

(47,216

)

 

(19,802

)

(55,459

)

 

 

 

 

 

 

 

Net loss per Subordinate and Multiple Voting Share

 

 

 

 

 

 

Basic and diluted

 

(0.09

)

(2.18

)

 

(0.91

)

(2.57

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per Subordinate and Multiple

 

-

 

-

 

 

0.02

 

0.02

 

Voting Share

 

(CA$ -

)

(CA$ -

)

 

(CA$0.03

)

(CA$0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total weighted average number of Subordinate and

 

 

 

 

 

 

Multiple Voting Shares

 

 

 

 

 

 

Basic and diluted

 

21,585,635

 

21,585,635

 

 

21,585,635

 

21,585,635

 


Consolidated Statements of Comprehensive Loss

(in thousands of U.S. dollars)

 

 

Three-month periods ended

 

 

Fiscal years ended

 

 

 

February 29,

 

February 28,

 

 

February 29,

 

February 28,

 

 

 

2024

 

2023

 

 

2024

 

2023

 

 

 

$

 

$

 

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the period

 

(2,089

)

(47,216

)

 

(19,802

)

(55,459

)

 

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

Foreign currency translation

 

(719

)

1,423

 

 

2,516

 

(8,985

)

 

 

 

 

 

 

 

Comprehensive loss

 

(2,808

)

(45,793

)

 

(17,286

)

(64,444

)

 

 

 

 

 

 

 

Comprehensive income (loss) attributable to:

 

 

 

 

 

 

Subordinate Voting Shares and Multiple Voting Shares

 

(2,802

)

(45,741

)

 

(17,221

)

(64,438

)

Non-controlling interest

 

(6

)

(52

)

 

(65

)

(6

)

 

 

 

 

 

 

 

Comprehensive loss

 

(2,808

)

(45,793

)

 

(17,286

)

(64,444

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss is composed solely of items that may be reclassified subsequently to the consolidated statement of loss.


Consolidated Statements of Changes in Equity

(in thousands of U.S. dollars, excluding number of shares)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity attributable to the Subordinate and Multiple Voting shareholders

 

 

 

 

Share capital

 

Contributed
surplus

 

Accumulated
other
comprehensive
loss

Retained
earnings

Total

Non-controlling
interest

Total equity

 

 

 

 

 

 

 

 

 

 

 

Balance - February 28, 2022

 

72,695

 

6,260

 

(32,126

)

217,995

 

264,824

 

686

 

265,510

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

-

 

-

 

-

 

(55,453

)

(55,453

)

(6

)

(55,459

)

Other comprehensive loss

 

-

 

-

 

(8,985

)

-

 

(8,985

)

-

 

(8,985

)

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss

 

-

 

-

 

(8,985

)

(55,453

)

(64,438

)

(6

)

(64,444

)

 

 

 

 

 

 

 

 

 

 

 

Acquisition of non-controlling interests

 

-

 

-

 

-

 

-

 

-

 

266

 

266

 

Other

 

-

 

-

 

(97

)

97

 

-

 

-

 

-

 

Dividends

 

 

 

 

 

 

 

 

 

 

Multiple Voting Shares

 

-

 

-

 

-

 

(366

)

(366

)

-

 

(366

)

Subordinate Voting Shares

 

-

 

-

 

-

 

(131

)

(131

)

-

 

(131

)

 

 

 

 

 

 

 

 

 

 

 

Balance - February 28, 2023

 

72,695

 

6,260

 

(41,208

)

162,142

 

199,889

 

946

 

200,835

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

-

 

-

 

-

 

(19,737

)

(19,737

)

(65

)

(19,802

)

Other comprehensive loss

 

-

 

-

 

2,516

 

-

 

2,516

 

-

 

2,516

 

 

 

 

 

 

 

 

 

 

 

 

Comprehensive loss

 

-

 

-

 

2,516

 

(19,737

)

(17,221

)

(65

)

(17,286

)

 

 

 

 

 

 

 

 

 

 

 

Acquisition of non-controlling interests

 

-

 

-

 

-

 

-

 

-

 

201

 

201

 

Dividends

 

 

 

 

 

 

 

 

 

 

Multiple Voting Shares

 

-

 

-

 

-

 

(354

)

(354

)

-

 

(354

)

Subordinate Voting Shares

 

-

 

-

 

-

 

(137

)

(137

)

-

 

(137

)

Non-controlling interest

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

Balance - February 29, 2024

 

72,695

 

6,260

 

(38,692

)

141,914

 

182,177

 

1,082

 

183,259

 


Consolidated Statements of Cash Flow

(in thousands of U.S. dollars)

 

 

Three-month periods ended

 

 

Fiscal years ended

 

 

 

February 29,

 

February 28,

 

 

February 29,

 

February 28,

 

 

 

2024

 

2023

 

 

2024

 

2023

 

 

 

$

 

$

 

 

$

 

$

 

 

 

 

 

 

 

 

Cash flows from

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

Net loss for the period

 

(2,089

)

(47,216

)

 

(19,802

)

(55,459

)

Adjustments to reconcile net loss to cash provided by operating activities

 

12,669

 

64,794

 

 

14,289

 

67,553

 

Changes in non-cash working capital items

 

9,069

 

911

 

 

9,814

 

(11,572

)

Cash provided by operating activities

 

19,649

 

18,489

 

 

4,301

 

522

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

Short-term investments

 

(5,254

)

9,367

 

 

(5,232

)

8,250

 

Additions to property, plant and equipment

 

(2,925

)

(1,385

)

 

(6,829

)

(4,370

)

Additions to intangible assets

 

(1,199

)

(903

)

 

(2,358

)

(2,219

)

Proceeds on disposal of property, plant and equipment

 

(127

)

141

 

 

(45

)

185

 

Net change in other assets

 

317

 

(117

)

 

347

 

(87

)

Cash provided (used) by investing activities

 

(9,198

)

7,103

 

 

(14,127

)

1,759

 

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

Dividends paid to Subordinate and Multiple Voting shareholders

 

-

 

-

 

 

(491

)

(497

)

Acquisition of non-controlling interests

 

1

 

266

 

 

201

 

266

 

Net change in revolving credit facility

 

-

 

(5,373

)

 

5,000

 

-

 

Increase in long-term debt

 

1,286

 

1,506

 

 

1,286

 

3,666

 

Repayment of long-term debt

 

(1,069

)

(683

)

 

(8,762

)

(4,398

)

Repayment of long-term lease liabilities

 

(603

)

(566

)

 

(1,895

)

(1,657

)

Cash provided (used) by financing activities

 

(385

)

(4,850

)

 

(4,661

)

(2,620

)

 

 

 

 

 

 

 

Effect of exchange rate differences on cash

 

17

 

200

 

 

679

 

(2,873

)

 

 

 

 

 

 

 

Net change in cash during the period

 

10,083

 

20,942

 

 

(13,808

)

(3,212

)

 

 

 

 

 

 

 

Net cash – Beginning of the period

 

26,362

 

29,311

 

 

50,253

 

53,465

 

 

 

 

 

 

 

 

Net cash – End of the period

 

36,445

 

50,253

 

 

36,445

 

50,253

 

 

 

 

 

 

 

 

Net cash is composed of:

 

 

 

 

 

 

Cash and cash equivalents

 

36,445

 

50,513

 

 

36,445

 

50,513

 

Bank indebtedness

 

-

 

(260

)

 

-

 

(260

)

 

 

 

 

 

 

 

Net cash – End of the period

 

36,445

 

50,253

 

 

36,445

 

50,253

 

 

 

 

 

 

 

 

Supplementary information

 

 

 

 

 

 

Interest paid

 

(845

)

(524

)

 

(1,274

)

(974

)

Income taxes paid

 

(2,523

)

(1,361

)

 

(6,708

)

(8,160

)